Insulin lispro-aabc

FDA Drug Profile — LYUMJEV, LYUMJEV KwikPen, LYUMJEV Tempo Pen, LYUMJEV Junior KwikPen

Insulin lispro-aabc is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including LYUMJEV, LYUMJEV KwikPen, LYUMJEV Tempo Pen. Available dosage form: injection, solution.

Drug Details

Generic Name
Insulin lispro-aabc
Brand Names
LYUMJEV, LYUMJEV KwikPen, LYUMJEV Tempo Pen, LYUMJEV Junior KwikPen
Application Number
BLA761109
Sponsor
A-S Medication Solutions
NDC Codes
13
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN LISPRO

Indications and Usage

1 INDICATIONS AND USAGE LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )